Document is current
Any future updates will be listed below
-
Authors
Nesic, Ksenija
Parker, Phoebe
Swisher, Elizabeth M.
Krais, John J.
-
Funding
Funding for this research was provided by:
AACR-AstraZeneca Ovarian Cancer Research Fellowship
National Health and Medical Research Council
Stafford Fox Medical Research Foundation
NIH NCI (R01CA251817, 1K22CA276631-01)
Alvin J. Siteman Cancer Center through The Foundation for Barnes-Jewish Hospital and the Alvin J. Siteman Cancer Research Fund
Ovarian Cancer Research Alliance (ECIG-2025-3-1966)
Cancer Research Foundation
Basser Center for BRCA
Route 66 Endometrial Cancer SPORE CEP
- License Information
-
More Information
Article History
Received: 17 July 2024
Accepted: 14 May 2025
First Online: 26 May 2025
Declarations
:
: Not applicable.
: Not applicable.
: K.N. reports research support (paid to institution) from AstraZeneca Pty Ltd and Boehringer Ingelheim outside the submitted work, and non-financial support from Clovis Oncology and Sierra Oncology. E.S. is on the Scientific Advisory Board for Ideaya Biosciences.
